VCNX — Vaccinex Cashflow Statement
0.000.00%
Last trade - 00:00- $1.78m
- $2.37m
- $0.60m
Annual cashflow statement for Vaccinex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -28.9 | -22.4 | -19.8 | -20.3 | -18.6 |
| Depreciation | |||||
| Non-Cash Items | 0.964 | 0.123 | 0.545 | -1.56 | 0.251 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.07 | -3.21 | -0.011 | 0.318 | 2.1 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -28.6 | -25.3 | -19.1 | -21.4 | -16.2 |
| Capital Expenditures | -0.29 | -0.032 | -0.099 | -0.067 | -0.022 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.29 | -0.032 | -0.099 | -0.067 | -0.022 |
| Financing Cash Flow Items | -0.763 | -0.985 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 36.8 | 23.3 | 17 | 16.6 | 15.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.82 | -2.01 | -2.2 | -4.86 | -0.428 |